Interviews Michael J. Kaldasch, Founder & CEO @ Aimedis B.V “First Medical NFT Marketplace & First Hospital Chain in the Metaverse”


 4,069 total views

1) Thanks for coming by Michael. Can you introduce yourself to us? Tell us about your background and experience, please. We would also like to know more about your core members, can you introduce them too?

So myself, the CEO and founder of Aimedis, is a medical doctor, drug safety officer and consultant. Always been into tech and IT, programmed since I was 15 years old, been into blockchain since 2016. Alongside is Ben, our COO and Founder of Aimedis. Ben is also a medical doctor with 12 years of experience in the medical space. He is an IT and crypto enthusiast and has been in crypto for years. We as a team have worked in internal medicine and the pharmaceutical space as well as tech. The advisors, as well as blockchain and crypto and medical advisors, are the strong background of the company and support us both with their know-how as well as a very strong network. The doctors supporting us are having a great clinical career and are among the best in the field. The blockchain side of advisors has been engaged in some of the best blockchain companies.


2) Can you tell us what is Aimedis all about?

Aimedis – an eHealth platform based on blockchain technology has been developed since 2017 and released in the current version 2020 for web, iOS and Android. Aimedis combines all relevant eHealth applications such as health records, video chat with doctors, appointments, prescriptions, second opinions, wearables, medical social media communication, eLearning, a unique medical and scientific-pharmaceutical NFT marketplace while displaying all relevant operations in a private blockchain, visible and transparent for the patient. Aimedis builds the first virtual hospital chain inside the metaverse and adds to this new and fascinating technology. The Aimedis platform also contains dedicated tools for professionals like the Aimedis Virtual Hospital information system and online rehab, integrating VR/AR into the process of rehabilitation. The Aimedis token, which is tailored to the platform, is much more than just utility and payment tokens, it also offers staking, governance, DeFi (the first medical DeFi token) and the next hot trend in the field of cryptocurrencies, social token functionalities. Aimedis has offices in the Netherlands, the UAE and the Philippines.


3) Walk us through your tokenomics and structure too. Thank you.

There are 600.000.000 AIMX tokens, from which 10% are sold during seed, private and public sale. Seed price: 0.03 USD, Private Sale: 0.04 USD, Public Sale: 0.05 USD.

The Aimedis token combines payment, utility, DeFi, governance and social token aspects.

While all kinds of services including NFT minting can be paid with the token at a 10% discount compared to all other payment options, the token is also used to incentivize people in the metaverse and social medical part. The token has a DeFi aspect as data in form of the NFTs can be leveraged. Governance as token holders will have the option to vote for certain functions/directions both in the metaverse / social part as well as functionalities in the platform itself. Certain functions are more complex or only available for token holders when it comes to advertising on the platform or using certain professional tools showing the utility aspect of Aimedis. Detailed tokenomics can be viewed here:

The other documents can be downloaded here:


4) How does your marketing activities look like for the next few weeks? And what have you done before?

The Aimedis marketing campaign for the token sale started more than 6 months ago, we have been exploring the blockchain space for years and it has always been part of the development process. We have been featured in well-known publications like BTC-Echo, Cointelegraph, CoinDesk and many more. Besides we have been part of many blockchain events, thus as the Future Blockchain Summit in Dubai, where we have also been represented at the Gitex and Expo fair itself as we are not only targeting the crypto community but also governments and healthcare institutions. We have been part of the World Economic Forum’s CyberPolygon 2021 and are also representing Aimedis @ Total Health Europe 2021 organized by Reuters Events. It is important as a healthcare company to strongly focus on both the blockchain market as well as the classical healthcare market, which is key to success.


5) What is your product and technology roadmap?

Aimedis is a platform available on both Android and ios where you can Store all your medical data
Connect your trackers and IoT devices
Interoperable with professional health IT
With Full right control and transparency.

It also offers Special tools for medical professionals with:
– Private videochat module
– eAppointment module for on- and offline appointments
– ePrescriptions
– eSick certificates
– Patient service modules

In terms of technology, Aimedis uses a private decentralized zero-knowledge blockchain for maximal transparency & trust.

A public blockchain for digital assets that can be used inside the ecosystem and the social medical network.

Unique patient/doctor ID system with KYC & anti-fraud mechanisms.

Flawless data exchange with other medical storage solutions.


6) You seem to have many components to your project. Where are your core revenue drivers for now and in the future?

Up to now classical services like tools for healthcare professionals, consultation and physician services have been core elements of revenue ( > 1.5M USD in 2020, > 3M USD in 2021). From this year the NFT and data market, as well as metaverse applications, will be added to this portfolio as well as SaaS parts like Aimedis Virtual Hospital and Rehab will add to this growth.


7) Tell us about your successful IDO.

The IDO target was exceeded by 300% in less than 12 hours so it was really successful, we are glad and proud the community honours what we do and what we plan for the future.


8) Where will you be listing next? What are your plans?

The first listing will be taking place on Probit. In the next step, we aim for more centralized exchanges and we are already in negotiations about it. Listing on DEXs are planned for the near future.


9) Have you started working with partners? Can you tell us about your current partnerships?

Yes, we are working with several hospitals and chains in Europe, Asia and Africa. Our community consists of patients, doctors, nurses, pharmacists, emergency workers and more from everywhere in the world. We are aiming for 1M users by end of 2021 and aim to grow even faster in 2022. We have also partnered with charity organizations e.g. from the US to bring medical education and support to people that are in need. Covid has even worsened the situation for a lot of people, thus we are trying to support them. Already this year we will start to support a big cancer trial with our NFT marketplace and are already aiming for the next project.


10) Leave us an inspiring quote, please. We want to hear from experts like you.

All will be fine!

Besides NFTs, the metaverse and we will change healthcare for good … now is the time to start into a new era of well-being.


Disclaimer: does not endorse any content or product on this page. While we aim at providing you all important information that we could obtain, readers should do their own research before taking any actions related to the company and carry full responsibility for their decisions, nor can this article be considered as investment advice or recommendations. Every investment and trading move involves risk, you should conduct your own research when making a decision.